AOS vs CAI · P/E 19, rev $1.00B vs rev $812.0M
Smith AO Corporation (AOS) versus Caris Life Sciences, Inc. Common Stock (CAI) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. CAI currently screens at market cap $5.22B.
Not investment advice. Open the AOS and CAI stock pages for the full models.
Not investment advice.